Jaguar Health (JAGX) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free JAGX Stock Alerts $0.18 +0.01 (+5.88%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJaguar Health (NASDAQ:JAGX) Now Covered by StockNews.comamericanbankingnews.com - April 22 at 2:16 AMWhy Jaguar Health Stock Is Up Todaymsn.com - April 17 at 2:20 AMGold Moves Higher; Morgan Stanley Earnings Top Viewsmarkets.businessinsider.com - April 17 at 2:20 AMWhy Is Jaguar Health (JAGX) Stock Up 44% Today?investorplace.com - April 16 at 11:34 AMS&P 500 Down 1%; Delta Air Lines Posts Upbeat Earningsbenzinga.com - April 10 at 3:37 PMJaguar Health shareholders approve reverse stock splitmsn.com - April 10 at 3:37 PMWhat Is Going on With Jaguar Health (JAGX) Stock Today?investorplace.com - April 10 at 10:40 AMJaguar Health, Inc.: Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholdersfinanznachrichten.de - April 10 at 1:23 AMWhy Jaguar Health Stock Is Soaring After-Hoursmsn.com - April 9 at 8:04 PMJaguar Health Full Year 2023 Earnings: US$1.79 loss per share (vs US$36.18 loss in FY 2022)finance.yahoo.com - April 3 at 9:48 AMJaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 2 at 1:47 PMJAGX Stock Earnings: Jaguar Health Misses Revenue for Q4 2023investorplace.com - April 1 at 2:08 PMJaguar Health, Inc.: Jaguar Health Reports 2023 Financial Resultsfinanznachrichten.de - April 1 at 10:51 AMWhat Wall Street expects from Jaguar Health's earningsmarkets.businessinsider.com - March 31 at 9:49 AMJaguar Health, Inc.edition.cnn.com - March 20 at 3:50 PMGEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to Marketfinance.yahoo.com - March 20 at 3:50 PMCapricor Therapeutics, Inc. (4LN2.F)finance.yahoo.com - March 15 at 6:58 PMWhat In The World Is Going On With Jaguar Health (JAGX) Stock?msn.com - March 1 at 1:22 PMJaguar Health, Inc.: Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliancefinanznachrichten.de - February 23 at 1:20 PMJaguar Health Incmoney.usnews.com - February 17 at 7:59 PMJaguar Health Announces FDA Agrees with Clinical Trial Protocol for Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogsfinance.yahoo.com - February 15 at 10:02 AMJaguar Health, Inc.: Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relieffinanznachrichten.de - February 14 at 7:03 PMJaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relieffinance.yahoo.com - February 14 at 9:03 AMJaguar Health, Inc. (JAGX)ca.finance.yahoo.com - February 12 at 10:59 AMJaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrheafinance.yahoo.com - February 12 at 10:59 AMJaguar Health Inc (JAGX)investing.com - January 31 at 10:06 AM'Rainforests Are Nature's Medicine Cabinets': Biotech Co. Performs Fresh Research On Traditional Plants For Modern Mental Health Challengesmsn.com - January 30 at 3:13 PMMagdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regionsfinance.yahoo.com - January 30 at 10:12 AMJaguar Health to Present January 31 at The Microcap Conference and Participate in a Fireside Chat February 1 at the Lytham Partners Investor Select Conferencefinance.yahoo.com - January 29 at 1:35 PMDog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health’s Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea (CTD)finance.yahoo.com - January 25 at 10:46 AMJaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - January 22 at 1:10 PMIssuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs)finance.yahoo.com - January 4 at 10:38 AMJaguar Health, Inc. (NASDAQ:JAGX) Not Doing Enough For Some Investors As Its Shares Slump 61%finance.yahoo.com - December 18 at 8:23 AMA Majority of Subjects in Jaguar Health's Placebo-Controlled Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Chose to Continue on to Stage IIfinance.yahoo.com - December 11 at 12:00 PMJaguar Health Inc JAGXmorningstar.com - December 8 at 7:54 PMMASCC (Multinational Association of Supportive Care in Cancer) Webinar on GI Toxicities from Cancer Therapies Made Possible by Grant From Napo Pharmaceuticals, a Jaguar Health Family Companyfinance.yahoo.com - December 7 at 11:07 AMStudy Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) Websitefinance.yahoo.com - December 6 at 10:06 AMFDA renews conditional approval for Jaguar canine chemo drugmsn.com - December 4 at 2:39 PMFDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea in Dogsfinance.yahoo.com - December 4 at 9:39 AMJaguar Health, Inc.: Jaguar Health to Present December 5 at the MedInvest Oncology Investor Conferencefinanznachrichten.de - November 30 at 9:03 AMJaguar Health to Present December 5 at the MedInvest Oncology Investor Conferencefinance.yahoo.com - November 30 at 9:03 AMJaguar Health falls after update on Phase 3 trial for plant-based drugmsn.com - November 22 at 5:49 PMJaguar Health’s stock drops after results supporting ‘paramount’ trial have not been received yetmsn.com - November 21 at 3:35 PMTop Line Data for Jaguar Health’s Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Forthcomingfinance.yahoo.com - November 21 at 3:35 PMJaguar Health, Inc. (NASDAQ:JAGX) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 15 at 6:28 PMFILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTSfinance.yahoo.com - November 15 at 1:56 AMJaguar Health, Inc.: Jaguar Health Reports Third Quarter 2023 Financial Resultsfinanznachrichten.de - November 14 at 8:54 PMJaguar Health Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 14 at 10:09 AMEarnings Preview For Jaguar Healthbenzinga.com - November 13 at 1:29 PMBreast Cancer Related Results of Groundbreaking Napo Pharmaceuticals (a Jaguar Health Family Company) Supported Study on Quality of Life for Cancer Patients and Survivors Accepted for Presentation at the December 2023 San Antonio Breast Cancer Symposiumfinance.yahoo.com - November 9 at 1:21 PM Get Jaguar Health News Delivered to You Automatically Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. JAGX Media Mentions By Week JAGX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JAGX News Sentiment▼0.000.32▲Average Medical News Sentiment JAGX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JAGX Articles This Week▼22▲JAGX Articles Average Week Get Jaguar Health News Delivered to You Automatically Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: DARE News APLM News GANX News CALC News NXTC News SCYX News XLO News IMRX News FIXX News AADI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JAGX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
